Literature DB >> 15542192

Structure and adsorption properties of commercial calcium phosphate adjuvant.

Dongping Jiang1, Gnanasiri S Premachandra, Cliff Johnston, Stanley L Hem.   

Abstract

Calcium phosphate adjuvant is a commercially available vaccine adjuvant that potentiates the immune response to antigens. Although its name suggests that it is Ca3(PO4)2, X-ray diffraction, FTIR spectroscopy, thermal analysis and the Ca/P molar ratio identify commercial calcium phosphate adjuvant as non-stoichiometric hydroxyapatite, Ca10-x (HPO4)x (PO4)6-x (OH)2-x, where x varies from 0 to 2. The surface charge is pH-dependent (point of zero charge = 5.5). Consequently, commercial calcium phosphate adjuvant exhibits a negative surface charge at physiological pH and electrostatically adsorbs positively charged antigens. The presence of hydroxyls allows calcium phosphate adjuvant to adsorb phosphorylated antigens by ligand exchange with surface hydroxyls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542192     DOI: 10.1016/j.vaccine.2004.06.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging.

Authors:  Maite Jauregui-Osoro; Peter A Williamson; Arnaud Glaria; Kavitha Sunassee; Putthiporn Charoenphun; Mark A Green; Gregory E D Mullen; Philip J Blower
Journal:  Dalton Trans       Date:  2011-03-11       Impact factor: 4.390

2.  Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: potential for vaccine applications.

Authors:  David Chiu; Weibin Zhou; Sathana Kitayaporn; Daniel T Schwartz; Kaja Murali-Krishna; Terrance J Kavanagh; François Baneyx
Journal:  Bioconjug Chem       Date:  2012-02-10       Impact factor: 4.774

Review 3.  Review of the Applications of Biomedical Compositions Containing Hydroxyapatite and Collagen Modified by Bioactive Components.

Authors:  Agnieszka Sobczak-Kupiec; Anna Drabczyk; Wioletta Florkiewicz; Magdalena Głąb; Sonia Kudłacik-Kramarczyk; Dagmara Słota; Agnieszka Tomala; Bożena Tyliszczak
Journal:  Materials (Basel)       Date:  2021-04-21       Impact factor: 3.623

4.  Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.

Authors:  Nikolas T Weissmueller; Heiko A Schiffter; Robert C Carlisle; Christine S Rollier; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2015-03-25

Review 5.  Developments in Vaccine Adjuvants.

Authors:  Farrhana Ziana Firdaus; Mariusz Skwarczynski; Istvan Toth
Journal:  Methods Mol Biol       Date:  2022

6.  Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.

Authors:  Brittany A Bailey; Kashappa-Goud H Desai; Lukasz J Ochyl; Susan M Ciotti; James J Moon; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2017-08-22       Impact factor: 4.939

7.  Active self-healing encapsulation of vaccine antigens in PLGA microspheres.

Authors:  Kashappa-Goud H Desai; Steven P Schwendeman
Journal:  J Control Release       Date:  2012-10-24       Impact factor: 9.776

Review 8.  Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.

Authors:  Bradford S Powell; Alexander K Andrianov; Peter C Fusco
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

Review 9.  Novel adjuvants & delivery vehicles for vaccines development: a road ahead.

Authors:  Teena Mohan; Priyanka Verma; D Nageswara Rao
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

10.  A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.

Authors:  Masato Abei; Toshiyuki Okumura; Kuniaki Fukuda; Takayuki Hashimoto; Masahiro Araki; Kazunori Ishige; Ichinosuke Hyodo; Ayae Kanemoto; Haruko Numajiri; Masashi Mizumoto; Takeji Sakae; Hideyuki Sakurai; Junko Zenkoh; Gerelchuluun Ariungerel; Yu Sogo; Atsuo Ito; Tadao Ohno; Koji Tsuboi
Journal:  Radiat Oncol       Date:  2013-10-16       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.